204 related articles for article (PubMed ID: 10889043)
1. Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions.
Banks GC; Li Y; Reeves R
Biochemistry; 2000 Jul; 39(28):8333-46. PubMed ID: 10889043
[TBL] [Abstract][Full Text] [Related]
2. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.
Reeves R; Edberg DD; Li Y
Mol Cell Biol; 2001 Jan; 21(2):575-94. PubMed ID: 11134344
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the HMGI(Y) family of architectural transcription factors.
Reeves R
Environ Health Perspect; 2000 Oct; 108 Suppl 5():803-9. PubMed ID: 11035986
[TBL] [Abstract][Full Text] [Related]
4. Interaction of high mobility group-I (Y) nonhistone proteins with nucleosome core particles.
Reeves R; Nissen MS
J Biol Chem; 1993 Oct; 268(28):21137-46. PubMed ID: 8407950
[TBL] [Abstract][Full Text] [Related]
5. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene.
Reeves R; Leonard WJ; Nissen MS
Mol Cell Biol; 2000 Jul; 20(13):4666-79. PubMed ID: 10848593
[TBL] [Abstract][Full Text] [Related]
6. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential.
Edberg DD; Bruce JE; Siems WF; Reeves R
Biochemistry; 2004 Sep; 43(36):11500-15. PubMed ID: 15350136
[TBL] [Abstract][Full Text] [Related]
7. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA.
Reeves R; Wolffe AP
Biochemistry; 1996 Apr; 35(15):5063-74. PubMed ID: 8664299
[TBL] [Abstract][Full Text] [Related]
8. FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.
Beckerbauer L; Tepe JJ; Cullison J; Reeves R; Williams RM
Chem Biol; 2000 Oct; 7(10):805-12. PubMed ID: 11033083
[TBL] [Abstract][Full Text] [Related]
9. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.
Cmarik JL; Li Y; Ogram SA; Min H; Reeves R; Colburn NH
Oncogene; 1998 Jul; 16(26):3387-96. PubMed ID: 9692546
[TBL] [Abstract][Full Text] [Related]
10. Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines.
Holth LT; Thorlacius AE; Reeves R
DNA Cell Biol; 1997 Nov; 16(11):1299-309. PubMed ID: 9407002
[TBL] [Abstract][Full Text] [Related]
11. High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation (review).
Wisniewski JR; Schwanbeck R
Int J Mol Med; 2000 Oct; 6(4):409-19. PubMed ID: 10998430
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein.
Nissen MS; Langan TA; Reeves R
J Biol Chem; 1991 Oct; 266(30):19945-52. PubMed ID: 1939057
[TBL] [Abstract][Full Text] [Related]
13. HMG-I/Y, a new c-Myc target gene and potential oncogene.
Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
[TBL] [Abstract][Full Text] [Related]
14. HMGI/Y proteins: flexible regulators of transcription and chromatin structure.
Reeves R; Beckerbauer L
Biochim Biophys Acta; 2001 May; 1519(1-2):13-29. PubMed ID: 11406267
[TBL] [Abstract][Full Text] [Related]
15. Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.
Piekielko A; Drung A; Rogalla P; Schwanbeck R; Heyduk T; Gerharz M; Bullerdiek J; Wiśniewski JR
J Biol Chem; 2001 Jan; 276(3):1984-92. PubMed ID: 11034995
[TBL] [Abstract][Full Text] [Related]
16. The HMG-I(Y) A.T-hook peptide motif confers DNA-binding specificity to a structured chimeric protein.
Banks GC; Mohr B; Reeves R
J Biol Chem; 1999 Jun; 274(23):16536-44. PubMed ID: 10347218
[TBL] [Abstract][Full Text] [Related]
17. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.
Tallini G; Dal Cin P
Adv Anat Pathol; 1999 Sep; 6(5):237-46. PubMed ID: 10472377
[TBL] [Abstract][Full Text] [Related]
18. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of HMG-I by protein kinase C attenuates its binding affinity to the promoter regions of protein kinase C gamma and neurogranin/RC3 genes.
Xiao DM; Pak JH; Wang X; Sato T; Huang FL; Chen HC; Huang KP
J Neurochem; 2000 Jan; 74(1):392-9. PubMed ID: 10617144
[TBL] [Abstract][Full Text] [Related]
20. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
Liu WM; Guerra-Vladusic FK; Kurakata S; Lupu R; Kohwi-Shigematsu T
Cancer Res; 1999 Nov; 59(22):5695-703. PubMed ID: 10582687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
